Downloads: 1 | Views: 12
Research Paper | Medical Science | India | Volume 10 Issue 5, May 2021
RITUXIMAB in Lupus Related Autoimmune Haemolytic Anemia
Mohnish Patel | Prashant Chotalia | Puja Srivastava | Sapan C Pandya
Abstract: The treatment of choice of warm antibody Autoimmune Hemolytic Anemia is still corticosteroids. While many centres have now adopted rituximab as the 2nd line agent over splenectomy, there is also data on upfront use of rituximab in Autoimmune Hemolytic Anemia / Idiopathic Thrombocytopenic Purpura. We report a case for the role of Rituximab in a patient of adult autoimmune haemolytic anaemia who was refractory to the conventional corticosteroid therapy. We have used rituximab early on in our patient with good response.
Keywords: Rituximab, Lupus, Autoimmune Haemolytic Anemia
Edition: Volume 10 Issue 5, May 2021,
Pages: 1052 - 1055
Similar Articles with Keyword 'Lupus'
Case Studies, Medical Science, India, Volume 10 Issue 7, July 2021Pages: 1033 - 1035
It's Not Always Lupus
Research Paper, Medical Science, India, Volume 11 Issue 7, July 2022Pages: 1359 - 1364
A Clinicopathological Study of Refractory Lupus Nephritis in Tertiary Care Hospital in North East India
Dr. Manjuri Sharma | Benjamin Sangma | Prodip Kumar Doley | Gayatri Pegu